Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Aesthetic Connect PCLBKK:TRP +0.49%47 5-Year Yield-on-Cost % is 6.13 as of Aug. 15, 2026, which is 39% above its 10-year median of 4.42. GuruFocus rates BKK:TRP with a GF Score™ of 47/100 and a GF Value™ of ฿6.00 (Significantly Undervalued). The stock has 4 warning signs investors should review. Among 276 Healthcare Providers & Services companies, Aesthetic Connect PCL ranks better than 79.35% on this metric.
Aesthetic Connect PCL's yield on cost for the quarter that ended in Mar. 2026 was 6.13.
The historical rank and industry rank for Aesthetic Connect PCL's 5-Year Yield-on-Cost % or its related term are showing as below:
BKK:TRP'
s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.57 Med: 4.42 Max: 6.19
Current: 6.13
During the past 5 years, Aesthetic Connect PCL's highest Yield on Cost was 6.19. The lowest was 0.57. And the median was 4.42.
BKK:TRP's 5-Year Yield-on-Cost % is ranked better than 79.35% of 276
companies
in the Healthcare Providers & Services industry
Industry Median: 2.91
vs BKK:TRP: 6.13
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Aesthetic Connect PCL 5-Year Yield-on-Cost % Related Terms
BKK:TRP vs HCA, THC, DVA: 5-Year Yield-on-Cost % Comparison
For the Medical Care Facilities subindustry, Aesthetic Connect PCL's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Aesthetic Connect PCL 5-Year Yield-on-Cost % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Aesthetic Connect PCL's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Aesthetic Connect PCL's 5-Year Yield-on-Cost % falls into.
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Aesthetic Connect PCL (BKK:TRP) has a 5-Year Yield-on-Cost % of 6.13 as of Aug. 15, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Aesthetic Connect PCL and its competitors. This is 39% above median its historical median of 4.42. Over the past decade, Aesthetic Connect PCL's 5-Year Yield-on-Cost % has ranged from 0.57 to 6.19. According to the industry distribution chart, Aesthetic Connect PCL ranks #57 out of 276 companies in the Healthcare Providers & Services industry, placing it in the top 20.7%.
Is Aesthetic Connect PCL's 5-Year Yield-on-Cost % too high?
Aesthetic Connect PCL's current 5-Year Yield-on-Cost % of 6.13 is 39% above median its 10-year median of 4.42. Over the past 10 years, this metric has ranged from a low of 0.57 to a high of 6.19. The Healthcare Providers & Services industry median 5-Year Yield-on-Cost % is 2.91. Aesthetic Connect PCL's value of 6.13 is 110.7% above this industry median. Based on the distribution chart, Aesthetic Connect PCL ranks #57 out of 276 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Aesthetic Connect PCL has a GF Score™ of 47/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Aesthetic Connect PCL's 5-Year Yield-on-Cost % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Aesthetic Connect PCL ranks #57 out of 276 companies for 5-Year Yield-on-Cost %. This places Aesthetic Connect PCL in the top 21% of its industry — outperforming the majority of peers. The industry median 5-Year Yield-on-Cost % is 2.91. Aesthetic Connect PCL's value of 6.13 is 110.7% above this benchmark. Historically, Aesthetic Connect PCL's own 5-Year Yield-on-Cost % has ranged from 0.57 to 6.19 over the past decade. While the company's 10-year median is 4.42 vs. the industry median of 2.91, Aesthetic Connect PCL has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Healthcare Providers & Services company?
The median 5-Year Yield-on-Cost % among Healthcare Providers & Services companies is 2.91, based on 276 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Aesthetic Connect PCL's current 5-Year Yield-on-Cost % of 6.13 is 110.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Aesthetic Connect PCL and its competitors. For the Healthcare Providers & Services industry, the median 5-Year Yield-on-Cost % is 2.91 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Aesthetic Connect PCL's current 5-Year Yield-on-Cost % is 6.13, which is 39% above median its own 10-year median of 4.42. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aesthetic Connect PCL stock overvalued right now?
Based on GuruFocus' analysis, Aesthetic Connect PCL (BKK:TRP) is currently considered Significantly Undervalued. The stock's GF Value™ is ฿6.00, compared to a current price of ฿4.10 — trading 31.7% below its estimated fair value. The current 5-Year Yield-on-Cost % is 6.13, which is 39% above median its 10-year median of 4.42 and 110.7% above the Healthcare Providers & Services industry median of 2.91. Aesthetic Connect PCL's overall GF Score™ is 47/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Aesthetic Connect PCL (BKK:TRP), the current 5-Year Yield-on-Cost % is 6.13 as of Aug. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Aesthetic Connect PCL (BKK:TRP) Overvalued in 2026?
Based on GuruFocus' analysis, Aesthetic Connect PCL stock appears to be undervalued.
The current stock price of ฿4.10 is trading 31.7% below its estimated GF Value™ of ฿6.00.
GuruFocus considers Aesthetic Connect PCL to be Significantly Undervalued.
Key valuation signals for BKK:TRP:
5-Year Yield-on-Cost %: 6.13 (39% above median its 10-year median of 4.42)
GF Value™: ฿6.00 vs. price of ฿4.10 (31.7% below fair value)
Industry Position: 110.7% above the Healthcare Providers & Services median (#57 of 276)
No single metric tells the full story. See the BKK:TRP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:TRP has been successfully added to your 
